Literature DB >> 2019482

Laser Doppler evaluation of skin vasomotor reflexes during sympathetic stimulation in normals and in patients with primary Raynaud's phenomenon.

H Wollersheim1, H Droste, J Reyenga, T Thien.   

Abstract

Laser Doppler flux measurements were used to determine skin blood flow in 12 patients with primary Raynaud's phenomenon and in 12 healthy age and sex matched control subjects. The vasoconstrictor response to standing, the Valsalva maneuver and a deep breath were used to diagnose local abnormalities of peripheral nerve sympathetic function and were found normal together with a normal catecholamine response to standing upright. However, baseline laser Doppler measured skin blood flow was lower in patients with primary Raynaud's phenomenon (p less than 0.01 in all 3 tests) while resting norepinephrine levels were higher (2.25 +/- 0.33 nmol/l) than in normals (1.31 +/- 0.11 nmol/l; p less than 0.01). These results are consistent with the existence of an elevated sympathetic nervous system activity at rest and a decreased baseline skin blood flow without signs of an excessive sympathetic and skin vascular responsiveness to sympathetic nervous system stimulation.

Entities:  

Mesh:

Year:  1991        PMID: 2019482

Source DB:  PubMed          Journal:  Int J Microcirc Clin Exp        ISSN: 0167-6865


  3 in total

1.  The effects of stress, anxiety, and outdoor temperature on the frequency and severity of Raynaud's attacks: the Raynaud's Treatment Study.

Authors:  K M Brown; S J Middaugh; J A Haythornthwaite; L Bielory
Journal:  J Behav Med       Date:  2001-04

2.  Effect of hand position on digit and ulnar artery vasoconstrictor reflexes.

Authors:  Einar P Wilder-Smith; Linda Liurong; Yaling Guo
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

3.  Skin blood flow and autonomic reactivity in human poikilothermia.

Authors:  M A MacKenzie; H C Wollersheim; J W Lenders; A R Hermus; T Thien
Journal:  Clin Auton Res       Date:  1996-04       Impact factor: 4.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.